Search Results - "Sacoto, Daniel"

Willingness to receive COVID-19 vaccination in people living with HIV/AIDS from Latin America by Ortiz-Martínez, Yeimer, López-López, Miguel Ángel, Ruiz-González, Carlos E, Turbay-Caballero, Valentina, Sacoto, Daniel H, Caldera-Caballero, Marcela, Bravo, Heyman, Sarmiento, Jheinner, Rodriguez-Morales, Alfonso J

“…Prior research has established some risk factors for an increased risk of severe disease and mortality from coronavirus disease 2019 (COVID-19). However, the…”
Get more information

Association Between Food Intake and Gastrointestinal Symptoms in Patients With Obesity by Ghusn, Wissam, Cifuentes, Lizeth, Campos, Alejandro, Sacoto, Daniel, De La Rosa, Alan, Feris, Fauzi, Calderon, Gerardo, Gonzalez-Izundegui, Daniel, Stutzman, Jessica, Hurtado, Maria Daniela, Camilleri, Michael, Acosta, Andres

“…Hunger, satiation, postprandial satiety, and hedonic eating constitute key food intake parameters. We aim to study whether these symptoms are associated with…”
Get full text

Genial.ly como estrategia de aprendizaje en estudiantes de educación General Básica by Ponce Sacoto, Daniel Hugo, Ochoa Encalada, Sergio Constantino

“…La presente investigación se realizó con el propósito de analizar, de qué manera el uso de las herramientas tecnológicas, específicamente de la plataforma…”
Get full text

COXSACKIE A, AN UNUSUAL ETIOLOGY OF ACUTE PERICARDITIS IN ADULTS by Quintanilla, Bryan S., Nriagu, Bede N., Sacoto, Daniel, Munguia, Cesar Arturo, Mushiyev, Savi

Get full text

Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity by Ghusn, Wissam, De la Rosa, Alan, Sacoto, Daniel, Cifuentes, Lizeth, Campos, Alejandro, Feris, Fauzi, Hurtado, Maria Daniela, Acosta, Andres

“…No retrospective cohort study has assessed the effectiveness of semaglutide at doses used in randomized clinical trials to treat obesity (ie, 1.7 and 2.4 mg)…”
Get full text

Precision Medicine and Obesity by Sacoto, Daniel, Hurtado, Maria Daniela, Acosta, Andres

“…Obesity is a chronic, relapsing, and multifactorial disease, with a rising prevalence and an associated high economic burden. Achieving successful and…”
Get more information

Real World Weight Loss Outcomes of Semaglutide in Patients With Overweight and Obesity by Ghusn, Wissam, De la Rosa, Alan, Cifuentes, Lizeth, Sacoto, Daniel, Campos, Alejandro, Feris, Fauzi, Hurtado, Maria Daniela, Acosta, Andres

“…Background: Obesity is a chronic and multifactorial disease, with a significant medical and economic burden. Semaglutide, a glucagon-like peptide-1 (GLP-1)…”
Get full text

Additive Effect of Obesity Phenotypes on Body Weight and Body Mass Index by Ghusn, Wissam, Cifuentes, Lizeth, Sacoto, Daniel, de la Rosa, Alan, Campos, Alejandro, Feris, Fauzi, Hurtado, Maria Daniela, Acosta, Andres

“…Background: Obesity originates from an imbalance between energy intake and expenditure. Changes in each of the energy intake components (satiation,…”
Get full text

Food Intake and Energy Expenditure Across the Lifespan of Adults with Obesity by Hurtado, Maria Daniela, Cifuentes, Lizeth, Campos, Alejandro, De la Rosa, Alan, Feris, Fauzi, Sacoto, Daniel, Ghusn, Wissam, Acosta, Andres

“…Background: The main regulators of body weight are food intake and energy expenditure. Hunger and satiation are important factors of food intake regulation,…”
Get full text

The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes by Ghusn, Wissam, Fansa, Sima, Anazco, Diego, Tama, Elif, Cifuentes, Lizeth, Gala, Khushboo, De La Rosa, Alan, Sacoto, Daniel, Campos, Alejandro, Feris, Fauzi, Hurtado, Daniela, Acosta, Andres

“…Aims To compare weight loss outcomes between patients starting semaglutide who had previously been on another anti‐obesity medication (AOM) compared to those…”
Get full text

Mo1915 REAL-WORLD WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES OF SEMAGLUTIDE: A 1-YEAR MULTI-SITE STUDY by Ghusn, Wissam, Fansa, Sima, Nicolalde, Bryan, De la Rosa, Alan, Cifuentes, Lizeth, Sacoto, Daniel, Anazco, Diego, Gala, Khushboo, Campos, Alejandro, Feris, Fauzi, Hurtado, Maria D., Acosta, Andres

Get full text

Mo1916 SEMAGLUTIDE WEIGHT LOSS AND METABOLIC PARAMETERS OUTCOMES IN PATIENTS AFTER BARIATRIC SURGERIES: A 1-YEAR MULTI-CENTERED STUDY by Ghusn, Wissam, Fansa, Sima, Nicolalde, Bryan, De la Rosa, Alan, Cifuentes, Lizeth, Sacoto, Daniel, Anazco, Diego, Gala, Khushboo, Hurtado, Maria D., Acosta, Andres

Get full text

Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study by Ghusn, Wissam, Fansa, Sima, Anazco, Diego, Tama, Elif, Nicolalde, Bryan, Gala, Khushboo, De la Rosa, Alan, Sacoto, Daniel, Cifuentes, Lizeth, Campos, Alejandro, Feres, Fauzi, Hurtado, Maria Daniela, Acosta, Andres

“…Background/Objective There are limited real-world studies assessing semaglutide weight loss and associated comorbidity and metabolic outcomes over periods ≥ 6…”
Get full text

Effects of a Short- and Long-term Fast on Reward Neural Activity in Patients With Obesity by Campos, Alejandro, Sacoto, Daniel, Ghusn, Wissam, Marek, Tomas, Silgado, Maria Laura Ricardo, Cifuentes, Lizeth, Hurtado, Maria Daniela, Dayyeh, Barham Abu, Camilleri, Michael, Port, John, Acosta, Andres

“…Background: Obesity is a complex disease characterized by dysregulation in energy intake. The reward circuitry of the central nervous system is essential in…”
Get full text

Tu1593: ROUX-EN-Y BYPASS SURGERY IN PATIENTS WITH PROOPIOMELANOCORTIN GENE VARIANTS: 2-YEAR MATCHED CASE-CONTROL STUDY by Gala, Khushboo, Cifuentes, Lizeth, Jassir, Fauzi Feris, Campos, Alejandro, Aguilera, Daniel Sacoto, Rosa, Alan De la, Ghusn, Wissam, Mcrae, Alison, Hurtado, Maria D., Acosta, Andres

Get full text

Tu1598: ASSOCIATION OF SATIATION AND WEIGHT GAIN: A RETROSPECTIVE 5-YEAR COHORT STUDY by Aguilera, Daniel Sacoto, Cifuentes, Lizeth, Campos, Alejandro, Ghusn, Wissam, Rosa, Alan De la, Jassir, Fauzi Feris, Burton, Duane D., Hurtado, Maria D., Camilleri, Michael, Acosta, Andres

Get full text

1156: A COMPARISON BETWEEN REAL WORLD WEIGHT LOSS OUTCOMES WITH ANTI-OBESITY MEDICATIONS BEFORE AND DURING COVID-19 PANDEMIC by Rosa, Alan De la, Ghusn, Wissam, Cifuentes, Lizeth, Campos, Alejandro, Aguilera, Daniel Sacoto, Jassir, Fauzi Feris, Busebee, Bradley, Hurtado, Maria D., Acosta, Andres

Get full text

S1632 Effect of Changes in Gastric Emptying and Low-Calorie Phenotype Tailored Diet on Weight Loss: Results From a 12-week Clinical Trial by Cifuentes, Lizeth, Ghusn, Wissam, Campos, Alejandro, Feris, Fauzi, Sacoto, Daniel, De la Rosa, Alan, Hurtado, Maria Daniela, Acosta, Andres

Get full text

Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants by Cifuentes, Lizeth, Campos, Alejandro, Sacoto, Daniel, Ghusn, Wissam, De la Rosa, Alan, Feris, Fauzi, McRae, Alison, Bublitz, Joshua T., Hurtado, Maria D., Olson, Janet, Acosta, Andres

“…To study differences in cardiovascular risk factors and diseases between patients with and without genetic variants in the leptin-melanocortin pathway. A…”
Get full text

6718 Pancytopenia in a Patient with Graves’ Disease: An Interesting Case of a Thyrogastric Syndrome by De Rosairo, Anne E, Patel, Dhara, Hernan Sacoto, Daniel, Belokovskaya, Regina, Franco-Akel, Alberto A

“…Abstract Disclosure: A.E. De Rosairo: None. D. Patel, MD: None. D.H. Sacoto, MD: None. R. Belokovskaya: None. A.A. Franco-Akel, MD: None. Introduction:…”
Get full text